185 related articles for article (PubMed ID: 12177657)
1. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
[TBL] [Abstract][Full Text] [Related]
2. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy.
Parissis JT; Adamopoulos S; Karatzas D; Paraskevaidis J; Livanis E; Kremastinos D
Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):164-8. PubMed ID: 15785303
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy.
Adamopoulos S; Parissis JT; Paraskevaidis I; Karatzas D; Livanis E; Georgiadis M; Karavolias G; Mitropoulos D; Degiannis D; Kremastinos DT
Eur Heart J; 2003 Dec; 24(24):2186-96. PubMed ID: 14659770
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
6. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
[TBL] [Abstract][Full Text] [Related]
7. Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy: comparison between nonobstructive and dilated-phase hypertrophic cardiomyopathy.
Zen K; Irie H; Doue T; Takamiya M; Yamano T; Sawada T; Azuma A; Matsubara H
Int Heart J; 2005 Mar; 46(2):231-44. PubMed ID: 15876807
[TBL] [Abstract][Full Text] [Related]
8. [Cardiopulmonary exercise testing and cytokines in chronic heart failure. Comparison of patients with ischaemic and with dilated cardiomyopathy].
Straburzyńska-Migaj E; Leśniewska K; Ochotny R; Straburyńska-Lupa A; Baszko A; Wiktorowicz K; Cieśliński A
Pol Arch Med Wewn; 2004 Jun; 111(6):693-701. PubMed ID: 15508792
[TBL] [Abstract][Full Text] [Related]
9. Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy.
Parthenakis FI; Patrianakos A; Prassopoulos V; Papadimitriou E; Nikitovic D; Karkavitsas NS; Vardas PE
Am J Cardiol; 2003 May; 91(10):1190-4. PubMed ID: 12745101
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure.
Petretta M; Condorelli GL; Spinelli L; Scopacasa F; de Caterina M; Leosco D; Vicario ML; Bonaduce D
Am Heart J; 2000 Dec; 140(6):E28. PubMed ID: 11100001
[TBL] [Abstract][Full Text] [Related]
11. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT
Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471
[TBL] [Abstract][Full Text] [Related]
12. Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy.
Högye M; Mándi Y; Csanády M; Sepp R; Buzás K
Am J Cardiol; 2004 Jul; 94(2):249-51. PubMed ID: 15246916
[TBL] [Abstract][Full Text] [Related]
13. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
Nozaki N; Yamaguchi S; Shirakabe M; Nakamura H; Tomoike H
Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
[TBL] [Abstract][Full Text] [Related]
14. [Activation and role of the tumor necrosis factor-alpha in congestive heart failure].
Bachetti T; Comini L; Agnoletti L; Gaia G; Milanesi B; Curello S; Corti A; Ferrari R; Visioli O
Cardiologia; 1996 Apr; 41(4):343-7. PubMed ID: 8674103
[TBL] [Abstract][Full Text] [Related]
15. [Myocardial remodeling and immunologic activation in patients with heart failure].
Rivera M; Taléns-Visconti R; Jordán A; Sirera R; Sevilla B; Climent V; Roselló E; Payá R; Cortés R; Sancho-Tello MJ; Valero R; González-Molina A
Rev Esp Cardiol; 2006 Sep; 59(9):911-8. PubMed ID: 17020704
[TBL] [Abstract][Full Text] [Related]
16. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA
Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria.
Grzanka R; Damasiewicz-Bodzek A; Kasperska-Zajac A
Allergy Asthma Clin Immunol; 2019; 15():15. PubMed ID: 30911316
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension.
Testa M; Yeh M; Lee P; Fanelli R; Loperfido F; Berman JW; LeJemtel TH
J Am Coll Cardiol; 1996 Oct; 28(4):964-71. PubMed ID: 8837575
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
[TBL] [Abstract][Full Text] [Related]
20. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Munger MA; Johnson B; Amber IJ; Callahan KS; Gilbert EM
Am J Cardiol; 1996 Apr; 77(9):723-7. PubMed ID: 8651123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
